Darunavir: a critical review of its properties, use and drug interactions

Item

http://www.wikidata.org/entity/Q26998856

description

2012 nî lūn-bûn

@nan

2012 թուականին հրատարակուած գիտական յօդուած

@hyw

2012 թվականին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Darunavir: a critical review of its properties, use and drug interactions

@ast

Darunavir: a critical review of its properties, use and drug interactions

@en

Darunavir: a critical review of its properties, use and drug interactions

@nl

type

Item

label

Darunavir: a critical review of its properties, use and drug interactions

@ast

Darunavir: a critical review of its properties, use and drug interactions

@en

Darunavir: a critical review of its properties, use and drug interactions

@nl

prefLabel

Darunavir: a critical review of its properties, use and drug interactions

@ast

Darunavir: a critical review of its properties, use and drug interactions

@en

Darunavir: a critical review of its properties, use and drug interactions

@nl

P1476

Darunavir: a critical review of its properties, use and drug interactions

@en

P2093

Cristina Helena dos Reis Serra

http://www.w3.org/2001/XMLSchema#string

Deirdre M. DArcy

http://www.w3.org/2001/XMLSchema#string

Hérida Regina Nunes Salgado

http://www.w3.org/2001/XMLSchema#string

Josilene Chaves Ruela Corrêa

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular Characterization of Clinical Isolates of Human Immunodeficiency Virus Resistant to the Protease Inhibitor Darunavir

A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability

Drug delivery systems in HIV pharmacotherapy: what has been done and the challenges standing ahead.

Pharmacokinetic interaction between darunavir boosted with ritonavir and omeprazole or ranitidine in human immunodeficiency virus-negative healthy volunteers.

Pharmacokinetics of darunavir/ritonavir and ketoconazole following co-administration in HIV-healthy volunteers.

Clinical pharmacokinetics of darunavir.

Prediction of solubility and permeability class membership: provisional BCS classification of the world's top oral drugs

Pure drug and polymer based nanotechnologies for the improved solubility, stability, bioavailability and targeting of anti-HIV drugs.

Mother-to-fetus transfer of antiviral drugs and the involvement of transporters at the placental barrier.

P-glycoprotein mediates efflux transport of darunavir in human intestinal Caco-2 and ABCB1 gene-transfected renal LLC-PK1 cell lines.

P304

102-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000339862

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hérida Regina Nunes Salgado

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22797653

http://www.w3.org/2001/XMLSchema#string